The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
New psychoactive substances: challenges for drug surveillance, control, and public health responses
Open accessAbstract
The rapid emergence since the mid-2000s of a large and diverse range of substances originally designed as legal alternatives to more established illicit drugs (pragmatically clustered and termed new psychoactive substances; [NPS]) has challenged traditional approaches to drug monitoring, surveillance, control, and public health responses. In this section of the Series, we describe the emergence of NPS and consider opportunities for strengthening the detection, identification, and responses to future substances of concern. First, we explore the definitional complexity of the term NPS. Second, we describe the origins and drivers surrounding NPS, including motivations for use. Third, we summarise evidence on NPS availability, use, and associated harms. Finally, we use NPS as a case example to explore challenges and opportunities for future drug monitoring, surveillance, control, and public health responses. We posit that the current means of responding to emerging substances might no longer be fit for purpose in a world in which different substances can be rapidly introduced, and where people who use drugs can change preferences on the basis of market availability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ESPAD report 2015 results from the European School Survey Project on Alcohol and Other Drugs.
Kraus, L., Guttormsson, U., Leifman, H., Arpa, S., Molinaro, S., Monshouwer, K., Trapencieris, M., Vicente, J., Arnarsson, Á. M., Balakireva, O. M., et al. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · doi:10.2810/022073 · Cited by 619
Freifeld, C. C., Mandl, K. D., Reis, B. Y., & Brownstein, J. S. (2008) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m2544 · Cited by 499
Comparing illicit drug use in 19 European cities through sewage analysis
Thomas, K. V., Bijlsma, L., Castiglioni, S., Covaci, A., Emke, E., Grabic, R., Hernández, F., Karolak, S., Kasprzyk-Hordern, B., Lindberg, R. H., et al. (2012) · Science of The Total Environment · doi:10.1016/j.scitotenv.2012.06.069 · Cited by 492
Self-citationFentanyl in the US heroin supply: A rapidly changing risk environment
Ciccarone, D. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.010 · Cited by 450
Larney, S., Peacock, A., Leung, J., Colledge, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K. V., Griffiths, P., Hines, L., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30373-x · Cited by 422
Self-citationOrt, C., van Nuijs, A. L. N., Berset, J., Bijlsma, L., Castiglioni, S., Covaci, A., de Voogt, P., Emke, E., Fatta‐Kassinos, D., Griffiths, P., et al. (2014) · Addiction · doi:10.1111/add.12570 · Cited by 394
Self-citation“Chemsex” and harm reduction need among gay men in South London
Bourne, A., Reid, D., Hickson, F., Torres-Rueda, S., Steinberg, P., & Weatherburn, P. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.07.013 · Cited by 335
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Adams, A. J., Banister, S. D., Irizarry, L., Trecki, J., Schwartz, M., & Gerona, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610300 · Cited by 320
ProMED-mail: An Early Warning System for Emerging Diseases
Yu, V. L., & Madoff, L. C. (2004) · Clinical Infectious Diseases · doi:10.1086/422003 · Cited by 267
Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261
Cited by
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Self-citationNew psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
Responding to global stimulant use: challenges and opportunities
Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., Ali, R., Tran, L. T., Rehm, J., Torrens, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32230-5 · Cited by 310
Self-citationOnaolapo, O. J., Olofinnade, A. T., Ojo, F. O., Adeleye, O., Falade, J., & Onaolapo, A. Y. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i10.1268 · Cited by 61
Three years of wastewater surveillance for new psychoactive substances from 16 countries
Bade, R., Rousis, N., Adhikari, S., Baduel, C., Bijlsma, L., Bizani, E., Boogaerts, T., Burgard, D. A., Castiglioni, S., Chappell, A., et al. (2023) · Water Research X · doi:10.1016/j.wroa.2023.100179 · Cited by 53
Self-citation
Metadata
- Authors
- Peacock, A., Bruno, R., Gisev, N., Degenhardt, L., Hall, W., Sedefov, R., White, J., Thomas, K. V., Farrell, M., & Griffiths, P.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 394
- Issue
- 10209
- Pages
- 1668-1684
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2981844663
- Cited by
- 360
- References
- 74
- FWCI
- 70.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New psychoactive substances: challenges for drug surveillance, control, and public health responses. https://app.cochat.ai/papers/10.1016/s0140-6736(19)32231-7
- The paper
- Peacock, A., Bruno, R., Gisev, N., Degenhardt, L., Hall, W., Sedefov, R., White, J., Thomas, K. V., Farrell, M., & Griffiths, P. (2019). New psychoactive substances: challenges for drug surveillance, control, and public health responses. The Lancet. https://doi.org/10.1016/s0140-6736(19)32231-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.